We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The U.S. ambassador and chargé d'affaires to Ethiopia announced earlier this week at the National Symposium on the Use and Management of Antiretroviral Treatment that the U.S. will donate a sum of $250 million to combat HIV/AIDS in the country, according to a local news source, The Daily Monitor.
The Bush administrations nomination of Andrew von Eschenbach to be the FDA commissioner faces an uncertain future that has less to do with the new Democratic Senate leadership than it does with members of the presidents own party.
The European Medicines Agency (EMEA) has posted on its website new guidance for submitting applications for generic and hybrid pharmaceutical products.
The Australian Therapeutic Goods Administration (TGA) has posted on its website updated guidelines on good manufacturing practice (GMP) clearance for drug manufacturers outside of Australia.
HIV treatment programs in Uganda could be disrupted following a decision by the Global Fund to fight Aids, Tuberculosis and Malaria to exclude the country from its list of beneficiaries, a senior government official told the UN Integrated Regional Information Networks (IRIN).
The UK Medicines and Healthcare products Regulatory Agency (MHRA) has granted the first product registration under the new European
Directive on traditional herbal medicinal products.
Japanese drugmaker Astellas Pharma announced that it has sought a declaratory judgment to confirm that a development and marketing agreement for the cholesterol drug Lipitor, marketed by Astellas in Japan, will continue until 2016.
Generex Biotechnology announced it has entered into an agreement with the Lebanese-Canadian Hospital in Beirut to conduct a human clinical trial of Antigen Express' synthetic avian influenza vaccine, representing the first studies of the vaccine to be conducted in humans.